As of 2024-12-12, the Intrinsic Value of Syneos Health Inc (SYNH) is
82.52 USD. This SYNH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 42.98 USD, the upside of Syneos Health Inc is
92.00%.
The range of the Intrinsic Value is 49.04 - 180.82 USD
82.52 USD
Intrinsic Value
SYNH Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
49.04 - 180.82 |
82.52 |
92.0% |
| DCF (Growth 10y) |
63.44 - 206.83 |
100.16 |
133.0% |
| DCF (EBITDA 5y) |
64.36 - 79.60 |
69.08 |
60.7% |
| DCF (EBITDA 10y) |
80.41 - 107.96 |
90.64 |
110.9% |
| Fair Value |
17.17 - 17.17 |
17.17 |
-60.06% |
| P/E |
19.09 - 78.97 |
44.88 |
4.4% |
| EV/EBITDA |
43.03 - 57.88 |
47.91 |
11.5% |
| EPV |
47.98 - 76.11 |
62.04 |
44.4% |
| DDM - Stable |
5.03 - 14.89 |
9.96 |
-76.8% |
| DDM - Multi |
36.39 - 86.01 |
51.40 |
19.6% |
SYNH Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
4,457.89 |
| Beta |
2.29 |
| Outstanding shares (mil) |
103.72 |
| Enterprise Value (mil) |
7,081.09 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.85% |
| Cost of Debt |
4.67% |
| WACC |
7.47% |